AstraZeneca is also looking to delist its Indian subsidiary.
The promoters’ holding arm recently raised funding from KKR.
Earlier, Fortis Healthcare spun off part of its business into a business trust in Singapore.
The India Equity Partners-backed company recently acquired majority stake in a Dehradun-based hospital.
Stock tanks as board defers approval to the voluntary offer which may cost over $100 million.
Good JV but why share price is not moving inspite of good quarterly numbers,
small equity and highest...
It is indeed a great success story with smart initiatives.
Dear Sir, Yes it is absolutely correct that MCA is creating confusion instead bringing clarity and overmore this is...
Like your rather 'simplistic' analysis- had been looking forward to it since the deal announcement.